Chromatin-mediated regulation of cytomegalovirus gene expression.
about
Bioactive Molecules Released From Cells Infected with the Human CytomegalovirusCytomegalovirus latency and reactivation: recent insights into an age old problem.Dynamic interactions between Bombyx mori nucleopolyhedrovirus and its host cells revealed by transcriptome analysisSnapshots: chromatin control of viral infection.Tegument protein control of latent herpesvirus establishment and animation.Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair responseThe life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomicsHistone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin.Epigenetically repressing human cytomegalovirus lytic infection and reactivation from latency in THP-1 model by targeting H3K9 and H3K27 histone demethylases.Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latencyThe rise of epigenetic targets for the development of novel antiviralsEpigenetic control of cytomegalovirus latency and reactivation.Canonical and variant forms of histone H3 are deposited onto the human cytomegalovirus genome during lytic and latent infectionsHistone modifications in herpesvirus infections.Epigenetic mechanisms as targets and companions of viral assaults.Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoterHuman cytomegalovirus manipulation of latently infected cells.Functional annotation of human cytomegalovirus gene products: an update.Epigenetic regulation of human cytomegalovirus latency: an update.Insertion of myeloid-active elements into the human cytomegalovirus major immediate early promoter is not sufficient to drive its activation upon infection of undifferentiated myeloid cells.Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.Role of codon usage and tRNA changes in rat cytomegalovirus latency and (re)activation.Modified Adenovirus Reduces De Novo Peritoneal Adhesions in Rats and Limits Off-Target Transfection. Role of EZH2 in Adhesion Formation.Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses.Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.Studies on HOXB4 expression during differentiation of human cytomegalovirus-infected hematopoietic stem cells into lymphocyte and erythrocyte progenitor cells.The chromatin remodeling factor SPOC1 acts as a cellular restriction factor against human cytomegalovirus by repressing the major immediate-early promoter.Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection.Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
P2860
Q26744665-5FE1370C-CDC9-45E0-A91E-DA2FD5AA6C30Q33761454-DA4407A8-5973-452D-82B3-D4EC5C42BED6Q34244826-D1EDAC16-2C69-4EAC-B789-B9E4B48D97A9Q34315920-7CEA3767-4246-4B02-B492-4B97551BA19CQ34712750-0409BD34-21DE-4987-BB86-CC3C73FF7D61Q34720787-1D170D72-7934-4AD7-9FD3-1788AF1D7190Q35665751-91B91B91-6CB9-4336-BC8A-62E6BACB04A7Q36159634-0210AEDD-DC00-4595-BAB6-D75C33C62A22Q36246288-970646B2-80BE-4D07-AA52-13E13B39B9C8Q36346073-7850077B-1435-45A3-9B13-F168296D9EABQ36652895-D4D1A4F6-4731-41D4-A408-6E9D31A913F4Q36657906-1CAE325C-DFA0-412D-8154-47CC90F1D449Q37015743-96CE2238-D188-437A-9923-AAFD207DE226Q37409252-8AB26FF7-F4C3-4CAE-86B2-414B35B61067Q37970405-5CB67112-8948-4F7A-94F8-3FDB6346DC3EQ37993608-0FD19934-9377-43AD-99F2-D3E26350914AQ38111995-CDBB85EC-C766-4F4B-A39F-E05D5309003FQ38166925-371416F1-4F24-457F-97CC-4C8954DF2C8CQ38218104-C2BF9777-B9AE-464A-AAA7-809F2FDC4F74Q38272313-2EEF158F-89A2-48D0-A5BA-D209881CA3C6Q39046934-8B5C5916-2F6F-42C4-A9E7-3E3A21F762EAQ39130826-47CE5FE0-6D80-4331-98BC-06DC2C3AB4EAQ39997880-E3F64886-4225-4BE2-8244-4022CEFCEE33Q40558694-B1AD7142-C964-4FE1-8D09-D7B4F4B0A4BFQ41893379-55D15C15-3350-46B9-B640-43D0F0A9F99FQ43079584-49773B3E-1868-41C6-B28D-0ED7964CE701Q52622831-0145C67F-F38F-42C8-AFCA-997CE849BEC4Q54216796-C45156A6-36C9-46B9-8DBD-96C3855439F2Q54254744-B317AB21-0FB2-4B9F-99A0-76BE734FD0F9Q55032738-CE62739F-9C10-4A6F-BDC0-F35E7999D5C1
P2860
Chromatin-mediated regulation of cytomegalovirus gene expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chromatin-mediated regulation of cytomegalovirus gene expression.
@en
Chromatin-mediated regulation of cytomegalovirus gene expression.
@nl
type
label
Chromatin-mediated regulation of cytomegalovirus gene expression.
@en
Chromatin-mediated regulation of cytomegalovirus gene expression.
@nl
prefLabel
Chromatin-mediated regulation of cytomegalovirus gene expression.
@en
Chromatin-mediated regulation of cytomegalovirus gene expression.
@nl
P2860
P1433
P1476
Chromatin-mediated regulation of cytomegalovirus gene expression
@en
P2093
Matthew B Reeves
P2860
P304
P356
10.1016/J.VIRUSRES.2010.09.019
P577
2010-09-25T00:00:00Z